APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Coagulation Factor IX

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Coagulation Factor IX Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchHuman Coagulation Factor IX Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Coagulation Factor IX Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Human Coagulation Factor IX Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Coagulation Factor IX Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Coagulation Factor IX Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Human Coagulation Factor IX market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Coagulation Factor IX include BPL, CSL, Greencross, Grifols, Kedrion, Octapharma, Baxter, Bayer and Biogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Coagulation Factor IX market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Coagulation Factor IX and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Coagulation Factor IX sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Coagulation Factor IX market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Coagulation Factor IX Segment by Company

BPL

CSL

Greencross

Grifols

Kedrion

Octapharma

Baxter

Bayer

Biogen

Hualan Bio

Pfizer

RAAS

Novo Nordisk

Human Coagulation Factor IX Segment by Type

AHGB

AHFB

Others

Human Coagulation Factor IX Segment by Application

Hospital

Personal Clinic

Others

Human Coagulation Factor IX Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor IX market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor IX and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor IX.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Coagulation Factor IX market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Coagulation Factor IX in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Coagulation Factor IX in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Coagulation Factor IX Industry Trends Table 2. Human Coagulation Factor IX Industry Drivers Table 3. Human Coagulation Factor IX Industry Opportunities and Challenges Table 4. Human Coagulation Factor IX Industry Restraints Table 5. Global Human Coagulation Factor IX Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Coagulation Factor IX Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Coagulation Factor IX Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Human Coagulation Factor IX Sales Market Share by Manufacturers Table 9. Global Human Coagulation Factor IX Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Human Coagulation Factor IX Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Coagulation Factor IX Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Coagulation Factor IX Manufacturers, Product Type & Application Table 13. Global Human Coagulation Factor IX Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Coagulation Factor IX by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of AHGB Table 17. Major Manufacturers of AHFB Table 18. Major Manufacturers of Others Table 19. Global Human Coagulation Factor IX Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 21. Global Human Coagulation Factor IX Sales by Type (2027-2032) & (k units) Table 22. Global Human Coagulation Factor IX Sales Market Share by Type (2021-2026) Table 23. Global Human Coagulation Factor IX Sales Market Share by Type (2027-2032) Table 24. Global Human Coagulation Factor IX Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Human Coagulation Factor IX Revenue by Type (2021-2026) & (k units) Table 26. Global Human Coagulation Factor IX Revenue by Type (2027-2032) & (k units) Table 27. Global Human Coagulation Factor IX Revenue Market Share by Type (2021-2026) Table 28. Global Human Coagulation Factor IX Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Personal Clinic Table 31. Major Manufacturers of Others Table 32. Global Human Coagulation Factor IX Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 34. Global Human Coagulation Factor IX Sales by Application (2027-2032) & (k units) Table 35. Global Human Coagulation Factor IX Sales Market Share by Application (2021-2026) Table 36. Global Human Coagulation Factor IX Sales Market Share by Application (2027-2032) Table 37. Global Human Coagulation Factor IX Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Human Coagulation Factor IX Revenue by Application (2021-2026) & (k units) Table 39. Global Human Coagulation Factor IX Revenue by Application (2027-2032) & (k units) Table 40. Global Human Coagulation Factor IX Revenue Market Share by Application (2021-2026) Table 41. Global Human Coagulation Factor IX Revenue Market Share by Application (2027-2032) Table 42. Global Human Coagulation Factor IX Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Human Coagulation Factor IX Sales by Region (2021-2026) & (k units) Table 44. Global Human Coagulation Factor IX Sales Market Share by Region (2021-2026) Table 45. Global Human Coagulation Factor IX Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Human Coagulation Factor IX Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Human Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 49. North America Human Coagulation Factor IX Sales by Country (2027-2032) & (k units) Table 50. Europe Human Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 52. Europe Human Coagulation Factor IX Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Human Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Human Coagulation Factor IX Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Human Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Human Coagulation Factor IX Sales by Country (2027-2032) & (k units) Table 59. Global Human Coagulation Factor IX Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Human Coagulation Factor IX Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Human Coagulation Factor IX Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Human Coagulation Factor IX Revenue Market Share by Region (2021-2026) Table 63. Global Human Coagulation Factor IX Revenue Market Share by Region (2027-2032) Table 64. BPL Company Information Table 65. BPL Business Overview Table 66. BPL Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. BPL Human Coagulation Factor IX Product Portfolio Table 68. BPL Recent Development Table 69. CSL Company Information Table 70. CSL Business Overview Table 71. CSL Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. CSL Human Coagulation Factor IX Product Portfolio Table 73. CSL Recent Development Table 74. Greencross Company Information Table 75. Greencross Business Overview Table 76. Greencross Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Greencross Human Coagulation Factor IX Product Portfolio Table 78. Greencross Recent Development Table 79. Grifols Company Information Table 80. Grifols Business Overview Table 81. Grifols Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Grifols Human Coagulation Factor IX Product Portfolio Table 83. Grifols Recent Development Table 84. Kedrion Company Information Table 85. Kedrion Business Overview Table 86. Kedrion Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Kedrion Human Coagulation Factor IX Product Portfolio Table 88. Kedrion Recent Development Table 89. Octapharma Company Information Table 90. Octapharma Business Overview Table 91. Octapharma Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Octapharma Human Coagulation Factor IX Product Portfolio Table 93. Octapharma Recent Development Table 94. Baxter Company Information Table 95. Baxter Business Overview Table 96. Baxter Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Baxter Human Coagulation Factor IX Product Portfolio Table 98. Baxter Recent Development Table 99. Bayer Company Information Table 100. Bayer Business Overview Table 101. Bayer Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Bayer Human Coagulation Factor IX Product Portfolio Table 103. Bayer Recent Development Table 104. Biogen Company Information Table 105. Biogen Business Overview Table 106. Biogen Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Biogen Human Coagulation Factor IX Product Portfolio Table 108. Biogen Recent Development Table 109. Hualan Bio Company Information Table 110. Hualan Bio Business Overview Table 111. Hualan Bio Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Hualan Bio Human Coagulation Factor IX Product Portfolio Table 113. Hualan Bio Recent Development Table 114. Pfizer Company Information Table 115. Pfizer Business Overview Table 116. Pfizer Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Pfizer Human Coagulation Factor IX Product Portfolio Table 118. Pfizer Recent Development Table 119. RAAS Company Information Table 120. RAAS Business Overview Table 121. RAAS Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. RAAS Human Coagulation Factor IX Product Portfolio Table 123. RAAS Recent Development Table 124. Novo Nordisk Company Information Table 125. Novo Nordisk Business Overview Table 126. Novo Nordisk Human Coagulation Factor IX Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Novo Nordisk Human Coagulation Factor IX Product Portfolio Table 128. Novo Nordisk Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Human Coagulation Factor IX Distributors List Table 132. Human Coagulation Factor IX Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Human Coagulation Factor IX Product Image Figure 2. Global Human Coagulation Factor IX Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Coagulation Factor IX Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Coagulation Factor IX Sales (2021-2032) & (k units) Figure 5. Global Human Coagulation Factor IX Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Coagulation Factor IX Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. AHGB Image Figure 9. AHFB Image Figure 10. Others Image Figure 11. Global Human Coagulation Factor IX Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Human Coagulation Factor IX Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Human Coagulation Factor IX Sales Market Share by Type (2021-2032) Figure 14. Global Human Coagulation Factor IX Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Human Coagulation Factor IX Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Human Coagulation Factor IX Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Personal Clinic Image Figure 19. Others Image Figure 20. Global Human Coagulation Factor IX Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Human Coagulation Factor IX Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Human Coagulation Factor IX Sales Market Share by Application (2021-2032) Figure 23. Global Human Coagulation Factor IX Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Human Coagulation Factor IX Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Human Coagulation Factor IX Revenue Market Share by Application (2021-2032) Figure 26. North America Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Human Coagulation Factor IX Sales Market Share by Country (2021-2032) Figure 28. U.S. Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Human Coagulation Factor IX Sales Market Share by Country (2021-2032) Figure 33. Germany Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Human Coagulation Factor IX Sales Market Share by Country (2021-2032) Figure 40. China Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Human Coagulation Factor IX Sales Market Share by Country (2021-2032) Figure 48. Brazil Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Human Coagulation Factor IX Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Human Coagulation Factor IX Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Human Coagulation Factor IX Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Figure 59. North America Human Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Figure 61. Europe Human Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Human Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Human Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Human Coagulation Factor IX Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Human Coagulation Factor IX Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • AHGB
  • AHFB
  • Others
Applications
  • Hospital
  • Personal Clinic
  • Others
Companies covered
  • BPL
  • CSL
  • Greencross
  • Grifols
  • Kedrion
  • Octapharma
  • Baxter
  • Bayer
  • Biogen
  • Hualan Bio
  • Pfizer
  • RAAS
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Coagulation Factor IX Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Coagulation Factor IX Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Coagulation Factor IX Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Coagulation Factor IX Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Coagulation Factor IX Market Dynamics
  1. 2.1 Human Coagulation Factor IX Industry Trends
  2. 2.2 Human Coagulation Factor IX Industry Drivers
  3. 2.3 Human Coagulation Factor IX Industry Opportunities and Challenges
  4. 2.4 Human Coagulation Factor IX Industry Restraints
3 Human Coagulation Factor IX Market by Manufacturers
  1. 3.1 Global Human Coagulation Factor IX Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Coagulation Factor IX Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Coagulation Factor IX Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Coagulation Factor IX Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Coagulation Factor IX Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Coagulation Factor IX Manufacturers, Product Type & Application
  7. 3.7 Global Human Coagulation Factor IX Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Coagulation Factor IX Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Coagulation Factor IX Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Coagulation Factor IX Tier 1, Tier 2, and Tier 3
4 Human Coagulation Factor IX Market by Type
  1. 4.1 Human Coagulation Factor IX Type Introduction
  2. 4.1.1 AHGB
  3. 4.1.2 AHFB
  4. 4.1.3 Others
  5. 4.2 Global Human Coagulation Factor IX Sales by Type
  6. 4.2.1 Global Human Coagulation Factor IX Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Human Coagulation Factor IX Sales by Type (2021-2032)
  8. 4.2.3 Global Human Coagulation Factor IX Sales Market Share by Type (2021-2032)
  9. 4.3 Global Human Coagulation Factor IX Revenue by Type
  10. 4.3.1 Global Human Coagulation Factor IX Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Human Coagulation Factor IX Revenue by Type (2021-2032)
  12. 4.3.3 Global Human Coagulation Factor IX Revenue Market Share by Type (2021-2032)
5 Human Coagulation Factor IX Market by Application
  1. 5.1 Human Coagulation Factor IX Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Personal Clinic
  4. 5.1.3 Others
  5. 5.2 Global Human Coagulation Factor IX Sales by Application
  6. 5.2.1 Global Human Coagulation Factor IX Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Coagulation Factor IX Sales by Application (2021-2032)
  8. 5.2.3 Global Human Coagulation Factor IX Sales Market Share by Application (2021-2032)
  9. 5.3 Global Human Coagulation Factor IX Revenue by Application
  10. 5.3.1 Global Human Coagulation Factor IX Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Coagulation Factor IX Revenue by Application (2021-2032)
  12. 5.3.3 Global Human Coagulation Factor IX Revenue Market Share by Application (2021-2032)
6 Global Human Coagulation Factor IX Sales by Region
  1. 6.1 Global Human Coagulation Factor IX Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Coagulation Factor IX Sales by Region (2021-2032)
  3. 6.2.1 Global Human Coagulation Factor IX Sales by Region (2021-2026)
  4. 6.2.2 Global Human Coagulation Factor IX Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Coagulation Factor IX Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Coagulation Factor IX Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Coagulation Factor IX Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Coagulation Factor IX Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Coagulation Factor IX Revenue by Region
  1. 7.1 Global Human Coagulation Factor IX Revenue by Region
  2. 7.1.1 Global Human Coagulation Factor IX Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Coagulation Factor IX Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Coagulation Factor IX Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Coagulation Factor IX Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Coagulation Factor IX Revenue (2021-2032)
  8. 7.2.2 North America Human Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Coagulation Factor IX Revenue (2021-2032)
  11. 7.3.2 Europe Human Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Coagulation Factor IX Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Coagulation Factor IX Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BPL
  2. 8.1.1 BPL Company Information
  3. 8.1.2 BPL Business Overview
  4. 8.1.3 BPL Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BPL Human Coagulation Factor IX Product Portfolio
  6. 8.1.5 BPL Recent Developments
  7. 8.2 CSL
  8. 8.2.1 CSL Company Information
  9. 8.2.2 CSL Business Overview
  10. 8.2.3 CSL Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSL Human Coagulation Factor IX Product Portfolio
  12. 8.2.5 CSL Recent Developments
  13. 8.3 Greencross
  14. 8.3.1 Greencross Company Information
  15. 8.3.2 Greencross Business Overview
  16. 8.3.3 Greencross Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Greencross Human Coagulation Factor IX Product Portfolio
  18. 8.3.5 Greencross Recent Developments
  19. 8.4 Grifols
  20. 8.4.1 Grifols Company Information
  21. 8.4.2 Grifols Business Overview
  22. 8.4.3 Grifols Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Grifols Human Coagulation Factor IX Product Portfolio
  24. 8.4.5 Grifols Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Human Coagulation Factor IX Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 Octapharma
  32. 8.6.1 Octapharma Company Information
  33. 8.6.2 Octapharma Business Overview
  34. 8.6.3 Octapharma Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Octapharma Human Coagulation Factor IX Product Portfolio
  36. 8.6.5 Octapharma Recent Developments
  37. 8.7 Baxter
  38. 8.7.1 Baxter Company Information
  39. 8.7.2 Baxter Business Overview
  40. 8.7.3 Baxter Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Baxter Human Coagulation Factor IX Product Portfolio
  42. 8.7.5 Baxter Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Human Coagulation Factor IX Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Biogen
  50. 8.9.1 Biogen Company Information
  51. 8.9.2 Biogen Business Overview
  52. 8.9.3 Biogen Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Biogen Human Coagulation Factor IX Product Portfolio
  54. 8.9.5 Biogen Recent Developments
  55. 8.10 Hualan Bio
  56. 8.10.1 Hualan Bio Company Information
  57. 8.10.2 Hualan Bio Business Overview
  58. 8.10.3 Hualan Bio Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hualan Bio Human Coagulation Factor IX Product Portfolio
  60. 8.10.5 Hualan Bio Recent Developments
  61. 8.11 Pfizer
  62. 8.11.1 Pfizer Company Information
  63. 8.11.2 Pfizer Business Overview
  64. 8.11.3 Pfizer Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pfizer Human Coagulation Factor IX Product Portfolio
  66. 8.11.5 Pfizer Recent Developments
  67. 8.12 RAAS
  68. 8.12.1 RAAS Company Information
  69. 8.12.2 RAAS Business Overview
  70. 8.12.3 RAAS Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 RAAS Human Coagulation Factor IX Product Portfolio
  72. 8.12.5 RAAS Recent Developments
  73. 8.13 Novo Nordisk
  74. 8.13.1 Novo Nordisk Company Information
  75. 8.13.2 Novo Nordisk Business Overview
  76. 8.13.3 Novo Nordisk Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Novo Nordisk Human Coagulation Factor IX Product Portfolio
  78. 8.13.5 Novo Nordisk Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Coagulation Factor IX Value Chain Analysis
  2. 9.1.1 Human Coagulation Factor IX Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Coagulation Factor IX Production Mode & Process
  6. 9.2 Human Coagulation Factor IX Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Coagulation Factor IX Distributors
  9. 9.2.3 Human Coagulation Factor IX Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst